Study of Yupingfeng Powder Treating Allergic Rhinitis (AR) | MicrobiomeTrials← Back to trialsNCT06608017
Study of Yupingfeng Powder Treating Allergic Rhinitis (AR)
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2025-03-27Est. Completion: 2026-12-31
Enrollment target: 140 participants Locations- Hong Kong Institute of Integrative Medicine, Shatin, Hong Kong
Other microbiome trials you might be interested in
Allergic Rhinitis
Allergic rhinitis is a common condition that affects adults as well as children and adolescents, often with impaired qua…
Bagnols-sur-Cèze, FranceCompleted Jul 18, 2026
Eosinophilic DiseaseImmune DeficiencyHaTSUrticaria AnaphylaxisElevated IgE Level
Background:
* Mast cells are responsible for most symptoms of allergic reactions. In some allergic diseases, it is unus…
Bethesda, United States